#conference-presentation

Immunic, Inc. (IMUX) présente à la 10e réunion conjointe ACTRIMS-ECTRIMS - MSToronto2026 - Diapositives (NASDAQ:IMUX) 27-10-2026

Immunic, Inc. presented at the 10th Joint ACTRIMS-ECTRIMS Meeting, sharing key updates via a slideshow. This presentation likely focused on the company's advancements in its research and development pipeline, particularly concerning its work in treating inflammatory diseases.